聚和材料(688503) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 2,993,996,794.13, representing a 1.38% increase compared to CNY 2,953,155,555.36 in the same period last year[3] - Net profit attributable to shareholders was CNY 89,653,255.21, an increase of 18.24% from CNY 75,820,998.98 year-on-year[3] - The net profit after deducting non-recurring gains and losses was CNY 88,586,887.29, reflecting a 5.90% increase from CNY 83,651,411.62 in the previous year[3] - Total operating revenue for Q1 2025 was CNY 2,993,996,794.13, a slight increase from CNY 2,953,155,555.36 in Q1 2024, representing a growth of approximately 1.4%[16] - Net profit for Q1 2025 reached CNY 88,000,715.86, compared to CNY 75,719,925.35 in Q1 2024, reflecting a growth of approximately 16.5%[17] - The total comprehensive income for Q1 2025 was CNY 96,674,355.93, compared to CNY 67,148,693.89 in Q1 2024, indicating a growth of approximately 43.9%[17] Cash Flow - The company's cash flow from operating activities showed a significant improvement, with a net cash flow of -CNY 118,723,764.85, compared to -CNY 1,282,072,447.70 in the same period last year[3] - In Q1 2025, the cash inflow from operating activities was CNY 2,858,924,656.37, an increase of 18.7% compared to CNY 2,407,421,724.12 in Q1 2024[19] - The net cash flow from operating activities was -CNY 118,723,764.85, improving from -CNY 1,282,072,447.70 in the same period last year[19] - The cash outflow for purchasing goods and services was CNY 2,642,999,185.40, down 24.3% from CNY 3,487,014,955.43 in Q1 2024[19] - The cash inflow from financing activities was CNY 570,369,940.63, a decrease of 51% compared to CNY 1,164,072,221.15 in Q1 2024[20] Assets and Liabilities - Total assets increased by 11.15% to CNY 8,865,341,271.42 from CNY 7,976,006,951.92 at the end of the previous year[4] - The company's current assets reached CNY 7,600,126,342.83, up from CNY 6,791,321,288.09, indicating an increase of about 11.93%[13] - The total liabilities as of March 31, 2025, are not explicitly stated but can be inferred to have increased alongside total assets[12] - Total liabilities as of the end of the reporting period were CNY 4,119,883,153.70, compared to CNY 3,333,701,000.79 in the previous year, representing an increase of approximately 23.6%[15] - The total liabilities increased to CNY 4,124,994,805.48 from CNY 3,564,720,239.85, indicating a rise of 15.7%[23] Shareholder Equity - Shareholders' equity attributable to the parent company rose by 2.26% to CNY 4,749,225,866.07 from CNY 4,644,421,160.13 at the end of the previous year[4] - Total equity attributable to shareholders increased to CNY 4,749,225,866.07 from CNY 4,644,421,160.13, showing a growth of about 2.3%[15] - The company's equity increased to CNY 4,909,500,617.94, up from CNY 4,804,554,244.00, showing a growth of 2.2%[23] Research and Development - Research and development (R&D) expenses totaled CNY 142,288,621.02, which is a decrease of 22.03% from CNY 182,480,676.96 in the previous year, accounting for 4.75% of operating revenue[4] - Research and development expenses for Q1 2025 were CNY 60,695,796.03, down from CNY 74,623,592.97 in Q1 2024, indicating a decrease of approximately 18.7%[16] - Research and development expenses decreased to ¥48,385,368.34 in Q1 2025 from ¥62,956,651.62 in Q1 2024, indicating a 23.3% reduction[25] Other Income and Expenses - Other income for Q1 2025 was CNY 47,226,517.49, significantly higher than CNY 15,257,485.15 in Q1 2024, reflecting an increase of about 209.5%[16] - The financial expenses for Q1 2025 were ¥5,892,549.45, slightly up from ¥5,291,007.85 in Q1 2024[25] - The company experienced a decrease in sales expenses, which were ¥6,481,242.11 in Q1 2025 compared to ¥8,127,268.62 in Q1 2024, reflecting a 20.2% reduction[25]